MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression.
Yasuda Y, Ozasa H, Kim YH, Yamazoe M, Ajimizu H, Yamamoto Funazo T, Nomizo T, Tsuji T, Yoshida H, Sakamori Y, Nakajima N, Menju T, Yoshizawa A, Date H, Hirai T.
Yasuda Y, et al. Among authors: nakajima n.
Cell Death Dis. 2020 Mar 9;11(3):177. doi: 10.1038/s41419-020-2379-2.
Cell Death Dis. 2020.
PMID: 32152266
Free PMC article.